Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults. (DREPSUFINDOL)
Sponsor: University Hospital, Bordeaux
This PHASE3 trial investigates Sickle Cell Crisis and is currently ongoing. University Hospital, Bordeaux leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Apr 2025 — Present [monthly]
Unknown PHASE3
Status: Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Apr 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
Dec 2021 — Apr 2023 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 5 earlier versions
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE3
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Oct 2019 — Jun 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Bordeaux
For direct contact, visit the study record on ClinicalTrials.gov .